ERBB2 and breast cancer: In naturally HER2-overexpressing human breast cancer cells SKBR3, HT concentrations up to 100 μM failed to elicit a cytotoxic response after 5 days, and only weakly interfered with cell proliferation, but reduced HER2 protein expression after 48 h.